Stanford Medicine proposes building an integrated care and research center in Redwood City

Wells Messersmith named director of CU Anschutz Cancer Center

Wells Messersmith was named director of the University of Colorado Anschutz Cancer Center, effective Oct. 1.

October 30, 2026

California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power

Throughout my career as a physician and scientist, I’ve seen ideas once considered impossible become breakthroughs that save lives. They happened because talented scientists had the resources, institutions, and sustained support to pursue ambitious ideas. Most importantly, they knew patients could not afford to wait.

October 23, 2026

Vol.52 No.39

By Arie S. Belldegrun

In Brief

Moffitt advances patient avatar technologies through $15M federal research initiative

Moffitt Cancer Center is advancing patient avatar technologies through a $15 million federally funded research initiative in collaboration with the Murtha Cancer Center Research Program at the Uniformed Services University of the Health Sciences in Bethesda, Maryland.

October 16, 2026

Vol.52 No.38

Clinical Roundup

Urine test may improve bladder cancer diagnosis and guide treatment decision, Stanford-led study finds

A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose people with bladder cancer more accurately than current standard methods. The test also allows physicians to not only assess the cancer’s response to treatment but to predict whether immunotherapy or chemotherapy is likely to be most effective for each patient.

October 09, 2026

Vol.52 No.37

Clinical Roundup

COA survey finds high bispecific therapy adoption among community oncology practices

The Community Oncology Alliance announced results from a national survey examining how independent community oncology practices deliver bispecific therapies on Sept. 22.

September 25, 2026

Vol.52 No.35

Clinical Roundup

Anti-seizure drug fights aggressive childhood brain tumors, Stanford Medicine-led study shows

An existing anti-seizure drug slows the growth of a devastating group of childhood cancers, according to the results of a Stanford Medicine-led study.

September 18, 2026

Vol.52 No.34

Stanford Medicine proposes building an integrated care and research center in Redwood City

YOU MAY BE INTERESTED IN

Wells Messersmith named director of CU Anschutz Cancer Center

California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power

Moffitt advances patient avatar technologies through $15M federal research initiative

Urine test may improve bladder cancer diagnosis and guide treatment decision, Stanford-led study finds

COA survey finds high bispecific therapy adoption among community oncology practices

Anti-seizure drug fights aggressive childhood brain tumors, Stanford Medicine-led study shows

Renew today!

Subscriber content

Never miss an issue!

Login

Stanford Medicine proposes building an integrated care and research center in Redwood City

YOU MAY BE INTERESTED IN

Wells Messersmith named director of CU Anschutz Cancer Center

California’s Prop 38 is an historic approach to funding medical research, immunologyThe $8.4B bond makes a long-term investment in a field with life-saving power

Moffitt advances patient avatar technologies through $15M federal research initiative

Urine test may improve bladder cancer diagnosis and guide treatment decision, Stanford-led study finds

COA survey finds high bispecific therapy adoption among community oncology practices

Anti-seizure drug fights aggressive childhood brain tumors, Stanford Medicine-led study shows

Never miss an issue!

Login

California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power